fda remove semaglutide from shortage list Hims & Hers stock falls 25% as curtails compounded GLP-1s A proposal seeks to remove

Medicaid coverage of GLP-1 receptor agonists for weight loss remains inconsistent nationwide, with approximately 40% of state programs covering these medications only for type 2 diabetes management rather than standalone weight reduction

Doan K, Seluk T, Alkan A

Trial data showed that Saxenda , in combination with a reduced-calorie diet and increased physical activity, resulted in significantly greater weight loss in some patients than reduced-calorie diet and physical activity alone

It is recommended that people who follow a vegan or vegetarian diet take one oral dose of 50100 micrograms per day

Spencer, L., Olawuni, B., & Singh, P